Pharma often gets flak for being an industry that moves slowly to change. But in reality, the sector is always on its toes and 2022 was no exception.
From major shifts in clinical trials aimed at achieving one of pharma’s most pressing goals — boosting research diversity — to strategies in advertising that evolved with the digital times to emerging technologies that provide new solutions to old challenges, the life sciences industry continues to innovate at a rapid clip.
We’ve tracked these trends by profiling standout executives who lead the charge to push the industry forward and capturing insights from experts with their ears to the ground. Before we say goodbye to another eventful year, here’s a look back at the articles from 2022 that our readers valued most.